PUBLIC COMPANY
saveRare Disease Therapeutics Inc
updated 3mo ago
community read0 votes
pipeline
3
marketed
3
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
3Marketed
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- STAT+: FDA approves Roivant therapy for rare autoimmune diseaseThe FDA approved a new medicine from Roivant and its subsidiary Priovant for the treatment of dermatomyositis, a rare autoimmune disease.stat · 26d ago
- Leo Pharma to license Tanabe’s rare disease drug for pain with sun exposureLeo Pharma said it will pay Japan’s Tanabe Pharma up to $435 million in upfront and near-term payments to license an oral drug for a pair of genetic light-sensitive skin diseases. The Danish biotec…endpoints · 1mo ago
- STAT+: Anthropic deepens work with rare disease drugsNovo Nordisk sues Eli Lilly over GLP-1s, Medicare pricing plans, and more biotech news from The Readoutstat · 2mo ago
comments(0)
5-min edit window · permanent after that